Evaluating the risk of SARS-CoV-2 reinfection with the Omicron or Delta variant in Wales, UK
Mark Postans(Public Health Wales), Christopher J.M. Williams(Hospital for Special Surgery)
Cited by 2
Related Papers
Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response
|Nature Reviews Clinical Oncology|2024|69